Malignant Peripheral Nerve Sheath Tumors Clinical Trials

20 clinical trials for Malignant Peripheral Nerve Sheath Tumors across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor — RECRUITING · PHASE1
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors — RECRUITING · PHASE2
• Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors — RECRUITING
• A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) — RECRUITING · PHASE2
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — RECRUITING · PHASE1
• MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Neurofibromatosis Type 1 Tumor Early Detection Study — ACTIVE_NOT_RECRUITING
• SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors — COMPLETED · PHASE2
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors — TERMINATED · PHASE1
• Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas — OTHER · PHASE2
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall — OTHER · PHASE2
• Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma — WITHDRAWN · PHASE1
• SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) — COMPLETED · PHASE1
• SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors — COMPLETED · PHASE2
• Trial of Dasatinib in Advanced Sarcomas — COMPLETED · PHASE2
• Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors — TERMINATED · PHASE2

Refine this search